Related Experiment Video
Updated: Jul 2, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Theranekron prevents endotoxin-induced acute kidney injury by modulating inflammatory and mitochondrial apoptotic
Atila Altuntas1, Halil Asci2, Ilter Ilhan3
1Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.
Background:
Lipopolysaccharide (LPS)-induced acute kidney injury (AKI) is characterized by oxidative stress, inflammation, and apoptotic injury. Theranekron (THERA) has been suggested to exert immunomodulatory effects; however, its impact on renal oxidative status and related molecular pathways remains unclear.
Methods:
Thirty-two male Wistar albino rats were allocated into four groups: Control, LPS, LPS + THERA, and THERA. Renal oxidative stress was assessed by measuring total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI). Serum creatinine and urea levels, histopathological alterations, and immunohistochemical expression of endothelial nitric oxide synthase (eNOS), interferon-gamma (IFN-γ), and interleukin-8 (IL-8) were evaluated. Sirtuin-1 (SIRT1), nuclear factor erythroid 2-related factor 2 (NRF2), heme oxygenase-1 (HO-1), B-cell lymphoma-2 (BCL2), BCL2-associated X protein (BAX), aquaporin-2 (AQP2), tumor necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10) gene expression were measured.
Results:
LPS significantly increased urea and creatinine levels and induced marked renal histopathological injury. Renal TAS was significantly decreased, and OSI was significantly increased. THERA treatment significantly increased TAS and reduced OSI compared with the LPS group. LPS significantly reduced SIRT1, NRF2, and HO-1 mRNA expression, and prophylactic THERA treatment significantly increased only HO-1 expression. LPS induced a pro-apoptotic shift and reduced AQP2 expression, all of which were significantly prevented by THERA. In parallel, THERA significantly reduced TNF-α expression and IL-10 levels, decreased IFN-γ and IL-8 immunoreactivity, and reduced eNOS immunoreactivity.
Conclusion:
Prophylactic THERA administration partially protected against early renal injury by improving renal antioxidant capacity, upregulating HO-1, and suppressing inflammatory and apoptotic responses, with preservation of AQP2 expression.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Pancreatitis II: Pathophysiology
Acute Inflammation III: Local and Systemic Effects
